Jeil Pharmaceutical Co.,Ltd

₩8,550As of Sun 8 Nov 2026, 12:00 UTC
KRX:271980Healthcare
Country South Korea
PE (Fwd) •••
TSR 9Y CAGR (17.45%)
Div yield —
ROE 9.11%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.62
PE TTM 13.42
TSR TTM (40.54%)
Mkt cap ₩125.7B
ROIC 1.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,389
9.81%
11.38%
Sell 3|6|4|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
107.32
106.27
114.00
125.20
32.92%
17.93%
30.90%
28.83%
Revenue₩B
14.87
14.71
15.26
15.33
2.87%
(3.52%)
—
1.23%
Peers (US$92.70M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.062
(0.026)
(0.023)
EBIT/Intx
0.738
2.927
2.685
Own earn%
(52.93)
1.03
2.15
Sh yield%
8.30
27.24
26.63
Owners
Insiders/Inst%
8.90
76.79
Short interest%
1.95
SBC / revenue%
1.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
22–31
$1 testx
—
Incr. ROIC%
14